Search

everythinglearnresearchcommunity

for

Search:↓

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Minoxidil in breast milk may harm nursing infants.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Certain molecules in hair change with age and could be used for cosmetic treatments.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.